# Neuromodulation of Inflammation and Vascular Function in Systolic Heart Failure

> **NCT03945058** · NA · TERMINATED · sponsor: **University of Oklahoma** · enrollment: 7 (actual)

## Conditions studied

- Heart Failure With Reduced Ejection Fraction

## Interventions

- **DEVICE:** TVS
- **DEVICE:** SHAM

## Key facts

- **NCT ID:** NCT03945058
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-02-04
- **Primary completion:** 2020-03-16
- **Final completion:** 2021-12-16
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Study was unable to meet target enrollment; no results generated.
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03945058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03945058, "Neuromodulation of Inflammation and Vascular Function in Systolic Heart Failure". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT03945058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*